135 related articles for article (PubMed ID: 30804269)
1. Musculoskeletal manifestations in end-stage renal disease patients on hemodialysis and relation to parathyroid dysfunction.
Afifi WM; Abo Elsaoud AM; Elgawish MH; Ghorab AM
Saudi J Kidney Dis Transpl; 2019; 30(1):68-82. PubMed ID: 30804269
[TBL] [Abstract][Full Text] [Related]
2. Musculoskeletal disorders in hemodialysis patients: different disease clustering according to age and dialysis vintage.
Hage S; Hage V; El-Khoury N; Azar H; Chelala D; Ziadé N
Clin Rheumatol; 2020 Feb; 39(2):533-539. PubMed ID: 31701366
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
4. Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients.
Zheng CM; Wu CC; Lu CL; Hou YC; Wu MS; Hsu YH; Chen R; Chang TJ; Shyu JF; Lin YF; Lu KC
Int J Med Sci; 2019; 16(12):1583-1592. PubMed ID: 31839746
[TBL] [Abstract][Full Text] [Related]
5. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
[TBL] [Abstract][Full Text] [Related]
7. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
O'Flaherty D; Sankaralingam A; Scully P; Manghat P; Goldsmith D; Hampson G
Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
[TBL] [Abstract][Full Text] [Related]
8. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
9. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
Bratisl Lek Listy; 2004; 105(10-11):368-73. PubMed ID: 15658577
[TBL] [Abstract][Full Text] [Related]
10. Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients.
Sit D; Kadiroglu AK; Kayabasi H; Atay AE; Yilmaz Z; Yilmaz ME
Adv Ther; 2007; 24(5):987-95. PubMed ID: 18029324
[TBL] [Abstract][Full Text] [Related]
11. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serum intact parathyroid hormone and pruritus in hemodialysis patients.
Makhlough A; Emadi N; Sedighi O; Khademloo M; Bicmohamadi AR
Iran J Kidney Dis; 2013 Jan; 7(1):42-6. PubMed ID: 23314141
[TBL] [Abstract][Full Text] [Related]
14. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients.
Lee SA; Lee MJ; Ryu GW; Jhee JH; Kim HW; Park S; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Yoo TH
Osteoporos Int; 2016 Sep; 27(9):2717-2726. PubMed ID: 27216997
[TBL] [Abstract][Full Text] [Related]
15. 7-84 parathyroid hormone fragments are proportionally increased with the severity of uremic hyperparathyroidism.
Chang JM; Lin SP; Kuo HT; Tsai JC; Tomino Y; Lai YH; Chen HC
Clin Nephrol; 2005 May; 63(5):351-5. PubMed ID: 15909594
[TBL] [Abstract][Full Text] [Related]
16. Profile of chronic kidney disease related-mineral bone disorders in newly diagnosed advanced predialysis diabetic kidney disease patients: A hospital based cross-sectional study.
Ray S; Beatrice AM; Ghosh A; Pramanik S; Bhattacharjee R; Ghosh S; Raychaudhury A; Mukhopadhyay S; Chowdhury S
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S931-S937. PubMed ID: 28728874
[TBL] [Abstract][Full Text] [Related]
17. The upper extremity musculoskeletal complications in dialysis patients: comparison between hemodialysis and peritoneal dialysis.
Soyupek F; Demir M; Süslü FE; Baykal B; Sezer MT; Yesildag A
J Back Musculoskelet Rehabil; 2013; 26(3):267-371. PubMed ID: 23893141
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric dimethylarginine, vascular calcifications and parathyroid hormone serum levels in hemodialysis patients.
Coen G; Mantella D; Sardella D; Beraldi MP; Ferrari I; Pierantozzi A; Lippi B; Di Giulio S
J Nephrol; 2009; 22(5):616-22. PubMed ID: 19809994
[TBL] [Abstract][Full Text] [Related]
19. Musculoskeletal manifestations of Fabry disease: A retrospective study.
Lidove O; Zeller V; Chicheportiche V; Meyssonnier V; Sené T; Godot S; Ziza JM
Joint Bone Spine; 2016 Jul; 83(4):421-6. PubMed ID: 26697993
[TBL] [Abstract][Full Text] [Related]
20. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
